Zobrazeno 1 - 10
of 408
pro vyhledávání: '"Nobumichi Tanaka"'
Autor:
Kuniaki Inoue, Shunta Hori, Mitsuru Tomizawa, Tatsuo Yoneda, Yasushi Nakai, Makito Miyake, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
IJU Case Reports, Vol 7, Iss 2, Pp 152-156 (2024)
Background Pseudoaneurysm formation sometimes complicates transplant nephrectomy. We report a case of bleeding from a pseudoaneurysm after transplantation nephrectomy that resulted in shock and emergency endovascular treatment. Case presentation A 56
Externí odkaz:
https://doaj.org/article/e11038d820b3494790f9ad4e3a6f3784
Autor:
Yusuke Iemura, Makito Miyake, Shinji Fukui, Tomomi Fujii, Sayuri Ohnishi, Shunta Hori, Yosuke Morizawa, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
Current Urology, Vol 17, Iss 4, Pp 229-235 (2023)
Abstract. Background. Radical cystectomy (RC) is the standard surgical treatment for patients with muscle-invasive bladder cancer, but the prognosis is not favorable, and new prognostic factors need to be discovered. We investigated the potential of
Externí odkaz:
https://doaj.org/article/8f8af00d9f764054a2fe44f949cdd66e
Autor:
Nobumichi Tanaka
Publikováno v:
Prostate International, Vol 11, Iss 3, Pp 127-133 (2023)
Around 40 years have passed since a modern low-dose-rate (LDR) brachytherapy for prostate cancer was introduced. LDR brachytherapy has become one of the definitive treatment options besides radical prostatectomy (RP) and external beam radiation thera
Externí odkaz:
https://doaj.org/article/bceea73a2d7c4f2384e61124601d41a9
Autor:
Nobutaka Nishimura, Makito Miyake, Tatsuki Miyamoto, Takuto Shimizu, Tomomi Fujii, Yosuke Morizawa, Shunta Hori, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
Advances in Urology, Vol 2024 (2024)
Background. Although routine surveillance imaging to examine upper urinary tract urothelial cancer recurrence during follow-up of nonmuscle invasive bladder cancer is recommended, its necessity remains invalidated. A single-institute long-term follow
Externí odkaz:
https://doaj.org/article/e91cdecc44f0431cb491562c39c1f728
Autor:
Shunta Hori, Keiichi Sakamoto, Kenta Onishi, Mitsuru Tomizawa, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Makito Miyake, Kazumasa Torimoto, Tatsuo Yoneda, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 6, Pp 2310-2318 (2023)
Objective: To compare the perioperative outcomes of patients with complex renal tumors treated with open versus robot-assisted partial nephrectomy. Methods: This retrospective study included 273 patients diagnosed with localized renal tumors at our i
Externí odkaz:
https://doaj.org/article/72f29e67ba234629abb4bf448555d565
Autor:
Takuto Shimizu, Makito Miyake, Nobutaka Nishimura, Takanori Yoshida, Yoshitaka Itami, Akira Tachibana, Chihiro Omori, Yuki Oda, Mikiko Kohashi, Mitsuru Tomizawa, Kenta Onishi, Shunta Hori, Yosuke Morizawa, Daisuke Dotoh, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
Cancers, Vol 16, Iss 4, p 841 (2024)
Complete metastasectomy (CM) in metastatic renal cell carcinoma (mRCC) has demonstrated efficacy in the cytokine era, but its effectiveness in the era of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) remains unclear. A mul
Externí odkaz:
https://doaj.org/article/450a3274d3d14010932a4d42316fcbb6
Autor:
Koji Mita, Kouji Izumi, Akihiro Goriki, Ryo Tasaka, Tomoya Hatayama, Takashi Shima, Yuki Kato, Manabu Kamiyama, Shogo Inoue, Nobumichi Tanaka, Seiji Hoshi, Takehiko Okamura, Yuko Yoshio, Hideki Enokida, Ippei Chikazawa, Noriyasu Kawai, Kohei Hashimoto, Takashi Fukagai, Kazuyoshi Shigehara, Shizuko Takahara, Yoshifumi Kadono, Atsushi Mizokami
Publikováno v:
Cancers, Vol 16, Iss 3, p 508 (2024)
Enzalutamide (ENZ) and abiraterone plus prednisolone (ABI) can improve the survival of patients with castration-resistant prostate cancer (CRPC). However, the agent that is more effective against nonmetastatic CRPC remains unclear. To evaluate the ag
Externí odkaz:
https://doaj.org/article/0c8d0708dc23486bb9e1a381da9eb6cf
Autor:
Nobutaka Nishimura, Makito Miyake, Takuto Shimizu, Akira Tachibana, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
IJU Case Reports, Vol 5, Iss 5, Pp 338-341 (2022)
Introduction Before the approval of enfortumab vedotin, no standard treatment was available as the salvage treatment for patients with metastatic urothelial carcinoma who had failed second‐line or later pembrolizumab. Pembrolizumab rechallenge is o
Externí odkaz:
https://doaj.org/article/0fbfc454d12a469abb13e9a283e6a175
Autor:
Kouji Izumi, Takashi Shima, Koji Mita, Yuki Kato, Manabu Kamiyama, Shogo Inoue, Nobumichi Tanaka, Seiji Hoshi, Takehiko Okamura, Yuko Yoshio, Hideki Enokida, Ippei Chikazawa, Noriyasu Kawai, Kohei Hashimoto, Takashi Fukagai, Kazuyoshi Shigehara, Shizuko Takahara, Yoshifumi Kadono, Atsushi Mizokami
Publikováno v:
European Urology Open Science, Vol 41, Iss , Pp 16-23 (2022)
Background: Enzalutamide (ENZ) and abiraterone plus prednisolone (ABI) improve survival in castration-resistant prostate cancer (CRPC). However, which agent is better for patients with CRPC remains unclear. Objective: To evaluate whether ENZ or ABI i
Externí odkaz:
https://doaj.org/article/8142d33ec52941b8af422dd7c8735ba5
Autor:
Hideyasu Tsumura, Nobumichi Tanaka, Tomohiko Oguchi, Takuya Owari, Yasushi Nakai, Isao Asakawa, Kazuyoshi Iijima, Haruaki Kato, Iwao Hashida, Ken-ichi Tabata, Takefumi Satoh, Hiromichi Ishiyama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract We compared clinical outcomes associated with seed brachytherapy (SEED-BT) alone and SEED-BT plus external-beam radiotherapy (EBRT) for intermediate-risk prostate cancer using propensity score-matched analysis. From 2006 to 2011, 993 patient
Externí odkaz:
https://doaj.org/article/0f03e922f93545728a406dc4f59cf354